
In a retrospective study investigated prognostic factors in lung cancer patients with interstitial lung disease (ILD). The study, which reviewed the medical records of 163 patients diagnosed with ILD-LC between January 2018 and May 2023, aimed to compare outcomes between idiopathic pulmonary fibrosis (IPF) and non-IPF ILD patients. Results showed no significant survival difference between the groups, but higher Krebs von den Lungen-6 levels were identified as a potential prognostic marker in ILD-LC patients.
Like
Save
Share